ICON plc has launched the ICON Signature Series, a thought leadership program that offers insight into clinical development strategies. It brings together industry experts to share knowledge and expertise across all aspects of clinical development and post-approval strategies via webinars, articles, whitepapers, symposia, workshops and videos. The program also offers an interactive discussion forum to engage with ICON and their industry peers on the latest trends and developments.
 
Dr. Mark Roseman, executive vice president, Global Scientific Operations at ICON, said, “Our global team comprises a powerhouse of deep insight in all fields related to clinical R&D. This, coupled with their practical experience in local markets makes them uniquely qualified to offer expert guidance on development practices, comment on emerging issues, and help steer the industry’s conversation on its future. The ICON Signature Series will be an invaluable resource to sponsor companies and is part of ICON’s on-going commitment to provide clients with strategic development solutions.”